| 词条 | Fagron |
| 释义 |
| name = Fagron NV | logo = | caption = | type = Public company[1] | traded_as = RCUS.BR on the Brussels Stock Exchange | genre = | fate = | predecessor = Omega Pharma (Professional health division) | successor = | foundation = | founder = | defunct = | location_city = Rotterdam | location_country = Netherlands[2] | locations = | area_served = Europe, South America and the United States[3] | key_people = | industry = Healthcare services and products | products = | services = | revenue = | operating_income = | net_income = | aum = | assets = | equity = | owner = | num_employees = over 2,000[2] | parent = | divisions = | subsid = | homepage = {{URL|https://fagron.com/en}} | footnotes = | intl = }} Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium,{{citation needed|date=May 2012}} and its headquarters is located at Rotterdam, Netherlands.[2] Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index (AScX). The head office of Fagron is located in Rotterdam (the Netherlands). OverviewFagron supplies products and services to professionals and institutions in the healthcare sector in Europe, the United States, Brazil and Argentina. The company comprises four company divisions:
Fagron was founded in Rotterdam (the Netherlands) in 1990 by Ger van Jeveren, the current CEO of the Fagron Group. Fagron is currently active in 29 countries in Europe, Africa, the Americas, Asia and the Pacific. Fagron products are sold to 150,000 customers in over 55 countries around the world. With 1,500 employees, Fagron generated a turnover of US$ 400 million in 2012. Pharmaceutical compounding - the creation and dispensing of tailor-made medications - is the root of the pharmacy profession often symbolised by the mortar and pestle. Compounding allows the pharmacist to work with the patient and the prescriber to customise medication to meet the patient’s specific needs. It regularly happens, for example, that patients need their medication in a dosage form or strength that is not available or that patients are allergic to an ingredient. In such situations, pharmaceutical compounding provides a tailor-made solution for the patient.
References1. ^{{cite web|url=http://www.brabantsdagblad.nl/algemeen/economie//article1962880.ece |title=Arseus goes public |publisher=Brabantsdagblad.nl |date=October 3, 2007 |accessdate=2012-05-20|language=nl}} {{Subscription required}} 2. ^1 2 {{cite web|url=http://www.arseus.com/en/profile |archive-url=https://web.archive.org/web/20090413181915/http://www.arseus.com/en/profile |dead-url=yes |archive-date=April 13, 2009 |title=Our company: Profile |publisher=arseus.com |accessdate=May 19, 2012 }} 3. ^1 2 3 4 {{cite web | url=http://in.reuters.com/finance/stocks/companyProfile?symbol=RCUS.BR | title=Profile: Arseus NV (RCUS.BR) | publisher=in.reuters.com | accessdate=May 19, 2012}} Further reading
Results: Arseus, Banc of America, Sony Ericsson, Mattel, Volkswagen |publisher=standaard.be |date=April 16, 2010 |accessdate=2012-05-20|language=nl}}
External links
3 : Companies based in Rotterdam|Health care companies of the Netherlands|Holding companies established in 2007 |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。